Abstract:The transcription factor CCAAT/enhancer‐binding protein β (C/EBPβ) is highly expressed in various tissues during development, including liver, adipose tissue, blood cells, lung and the endocrine pancreas. Two isoforms of C/EBPβ namely liver‐enriched activator protein (LAP) and liver‐enriched inhibitor protein (LIP) translated from the same mRNA have been described. The LAP and LIP isoforms share the same C‐terminal DNA binding domain except LAP has an extra N‐terminal activation domain. Probably due to its higher affinity for its DNA cognate sequences, the LIP can counteract the effects of LAP isoforms even at substoichiometric levels. In vitro and in vivo experiments with cultured cells and knockout mice demonstrated that C/EBPβ play a critical role in the regulation of myofibroblast differentiation and bleomycin induced pulmonary fibrosis. However, the regulatory mechanism of C/EBPβ gene expression is unclear. Analysis of the C/EBPβ promoter sequence identified a conserved P53 response element (P53RE) in the C/EBPβ gene promoter. Gel shift mobility and chromatin immunoprecipitation assays confirmed that P53 binds to the P53RE. Promoter reporter assays and real time PCR analysis of samples from fibroblasts transiently transfected with P53 or dominant negative P53 expression plasmids indicated that P53 was a repressor of C/EBPβ gene transcription. Western blot analysis with protein extracts from similarly transfected fibroblasts or P53 deficient fibroblasts showed that P53 differentially regulated translation of the C/EBPβ LAP and LIP isoforms through the regulation of eIF4E and eIF4E‐BP1. Further studies with constructs containing the LAP 5′ untranslated region or the LIP 5′ untranslated region showed that the 5′ untranslated region is important in differential control of C/EBPβ LAP and LIP translation. Thus P53 could regulate C/EBPβ gene expression at both transcriptional and translational levels. Support or Funding Information This work was supported by grants HL052285 and HL112880 from the National Institute of Health.

NF-κB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1

Arginine Methylation of Hnrnp K Enhances P53 Transcriptional Activity.

Ninjurinl, A Target Of P53, Modulates P53-Dependent Tumor Suppression In Vivo

Abstract 675: Ninjurin1, a Target of P53, Modulates P53-Dependent Tumor Suppression in Vivo

Post-translational regulation of p53 function through 20S proteasome-mediated cleavage

The RNF20/40 complex regulates p53-dependent gene transcription and mRNA splicing

NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53

Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms

Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response

P53 regulates mitochondrial biogenesis via transcriptionally induction of mitochondrial ribosomal protein L12

Preferential translation of p53 target genes

Cellular adaptation to hypoxia and p53 transcription regulation

Transcriptional and translational regulation of CCAAT/Enhancer Binding Protein β expression by P53

The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation

Regulation of MCP-1 chemokine transcription by p53

Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin

BAC transgenic mice provide evidence that p53 expression is highly regulated in vivo

Ribosomal Protein S27-like is a Physiological Regulator of P53 That Suppresses Genomic Instability and Tumorigenesis

A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop

The Transitional Endoplasmic Reticulum ATPase P97 Regulates the Alternative Nuclear Factor NF-κB Signaling Via Partial Degradation of the NF-κB Subunit P100*

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells